StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Vertex (VRTX) PT Raised to $459 at Morgan Stanley
February 11, 2025 7:10 AM
Morgan Stanley analyst Terence Flynn raised the price target on Vertex (NASDAQ ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst PT Change
Next Articles
BMO Capital Expects '2 New Launches to Drive 2025 PnL' for Vertex (VRTX)
February 11, 2025 7:09 AM
Vertex (VRTX) PT Raised to $450 at Scotiabank
February 11, 2025 6:52 AM
Piper Sandler: 'Vertex (VRTX) Firing on All Cylinders'
February 11, 2025 6:50 AM
Cantor Fitzgerald Reiterates Overweight Rating on Vertex (VRTX)
February 11, 2025 6:39 AM
Vertex (VRTX) PT Raised to $555 at BofA Securities
February 11, 2025 6:26 AM
Vertex (VRTX) PT Raised to $444 at Bernstein After Journavx and Alyftrek Launches
February 11, 2025 5:44 AM
Vertex forecasts upbeat 2025 revenue on cystic fibrosis treatments demand
February 10, 2025 4:13 PM
Form 8-K VERTEX PHARMACEUTICALS For: Feb 04
February 10, 2025 4:08 PM
Vertex Pharma (VRTX) Misses Q4 EPS by 4c, Revenues Beat
February 10, 2025 4:04 PM
Vertex Reports Fourth Quarter and Full Year 2024 Financial Results
February 10, 2025 4:01 PM
Vertex Pharma (VRTX) call put ratio 5.1 calls to 1 put with a focus on February 14 weekly calls into quarter results
February 7, 2025 10:26 AM
Vertex (VRTX) PT Raised to $501 at JPMorgan
February 7, 2025 8:59 AM
Vertex Pharma (VRTX) call put ratio 2.8 calls to 1 put into quarter results
February 7, 2025 5:03 AM
